Committed to Medical Innovations
Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.
Denali Therapeutics, a an early-stage biotech developing novel therapies for neurodegenerative diseases, raised $250 million by offering 13.9 million shares at $18, within the range of $17 to $19. At pricing, the company commands a fully diluted market value of $1.7 billion.Read More
The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of Artificial Intelligence. The Forum is a global gathering of more than 1,300 senior health care leaders in the heart of Boston. The event will bring together industry-leading CEOs, Partners’ HIT experts, investors and deal makers to share perspectives on how cognitive computation,…Read More
The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of Artificial Intelligence. The event will bring together industry-leading CEOs, Partners' HIT experts, investors and deal makers to share perspectives on how cognitive computation, machine learning, and big date are having a transformative impact on patient care.
Innovation Symposium Series
The Innovation Symposium Series is a five-part speaker series focused on navigating the innovation lifecycle. The Symposium Series is a complimentary, invitation-only gathering that encourages innovation and recognizes the entrepreneurial spirit of our research community. It is open to any PHS-affiliated investigator, clinician and administrator working on, or considering, research that will enhance the care continuum, improve the patient experience and increase positive outcomes. Attendees will hear from Innovation staff, HIT experts, investors and deal-makers from industry, venture, government and academia.